VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
Â
SBRT PROSTATE PLANNING
1. APPROACH TOWARDS
PROSTATE SBRT PLANNING
DR KANHU CHARAN PATRO
MD,DNB(RADIATION ONCOLOGY),MBA,FICRO,FAROI,PDCR,CEPC
HOD,RADIATION ONCOLOGY
Mahatma Gandhi Cancer Hospital And Research Institute,
Visakhapatnam, India
drkcpatro@gmail.com /M+91-9160470564
11/6/2022 1
4. Introduction
• The radiobiology of PCa with its low α/β-ratio and the slow cell proliferation
are considered to make PCa sensitive to a high dose per fraction and thus
hypofractionation advantageous, especially in terms of radiobiological
efficacy.
• Various fractionation schemes have been reported in SBRT literature, but
the optimal total dose and dose per fraction are still unknown
• The use of ultra-hypofractionated (≥ 5 Gy / fraction) external beam
radiotherapy (EBRT) is emerging as the primary treatment modality in
clinically localized prostate cancer (PCa).
• It can be delivered as stereotactic body radiotherapy (SBRT) by using an
image guided robotic[Cyber-KNIFE] or a gantry-based [LINAC-X-KNIFE]
device
11/6/2022 4
5. Treatment
protocols
Immobilization as available[knee
rest/vaclok/mask]
Alternate day treatment
CT simulation day and every treatment day
enema
CT simulation day and every treatment day
bladder filling procedure
Daily CBCT
Give some steroid during treatment day and
tapper
IPSS score will increase during treatment
11/6/2022 5
9. Patient Selection
• Current evidence for SBRT in prostate cancer relates mainly
to patients with low and intermediate-risk disease, with
selected cases of high risk PCa although definitions may vary
between studies.
• Long term series with excellent local control and minimal
toxicities very convincing for SBRT. (Katz et al, King et al
Pooled Analysis, Kishan et al, SHARP Consortium)
• IPSS score less than 10
• No TURP
• Ongoing studies for High Risk, Very High Risk and Node
Positive Prostate Cancer.
11/6/2022 9
25. STEP BY STEP ANALYSIS
11/6/2022 25
COSID INDEX
C COVERAGE INDEX
O OAR INDEX
S SPILLAGE INDEX
I IMAGING INDEX
D DELIVERY INDEX
Kanhu et.al/J CURR ONCO/2022
26. IMAGING
PROTOCOL
SUPINE WITH KNEE REST
DESIRABLE FULL COMFORTABLE BLADDER
EMPTY RECTUM
AXIAL CECT [Arterial and delayed phase-10 min]
T2 MRI 3 PLANE [A/C/S]
2-3 mm slice
UPPER BORDER OF KIDNEY TO MID THIGH
ANAL VERGE MARKER
11/6/2022 26
38. ABCDEF OF PROSTATE CONTOURING
A
• ANI-LEVATOR ANI
B
• BULB-PENILE BULB,
• BLADDER BASE
C
• CANAL-ANO RECTAL
CANAL
D
• DIAPHRAGM-
GENITOURINARY
DIAPHRAGM
• DEFERENT DUCT
E-EXTRA
STRUCTURES LIKE
• NEUROVASCULAR
BUNDLE
• URETHRA
• VENOUS PLEXUS
OF SANTORINI
F-FIBROMUSCULAR
STROMA
FIBROMUSCULAR
STROMA
11/6/2022 38
39. TARGET DELINEATION
• CTV P: according to ESTRO ACROP guidelines
• CTV N:
• Contoured by giving a radial margin of 5 to 7mm around the common iliac, external iliac,
internal iliac, presacral and the obturator vessels and editing from muscles and bones
• Cranial extent of CTV nodes: at the level of L5–S1 vertebra
• Caudal extent: at the level obturator nodes
• Seminal vesicle: 1.5cm when no involvement; entire SV if involved
• PTV P & PTV N:
• 5mm to the CTV P (including SV) and CTV N. posterior 5mm
11/6/2022 39
47. Why only 36.25Gy? Any specific reason?
If the α/β of prostate cancer is as low
as 1.5, then SBRT dose of 36.25 Gy in
5 fractions has a biologically effective
dose (BED) of 211 Gy, which is higher
than 78 Gy in 39 fractions (BED 182
Gy), but has a slightly lower BED (124
Gy vs 130 Gy) in terms of late rectal
toxicity, assuming an α/β of 3.
SLIDE FROM Dr ABHILASH
11/6/2022 47
48. DOSE SELECTION
DOSE :
36.25Gy in 5# to the Prostate
30Gy in 5# to the Gross node
25Gy in 5# to the Elective nodal region
11/6/2022 48
49. DOSE
PROSTATE
• 36.25Gy IN 5 #
NEGATIVE NODE
• 25Gy IN 5 #
POSITIVE NODES
• 25Gy IN 5 #
• GROSS NODE
30-35Gy IN 5 #
11/6/2022 49
78. Summary
SBRT is an excellent treatment modality for localized prostate cancer
endorsed by ASTRO, ASCO, AUA, NCCN
Relatively short follow-up time in prospective studies and few high-risk
patients included in the trials are limitations of this technique
While oncologic outcomes appear to be comparable with other EBRT
techniques, side effects occur earlier but resolve sooner
Careful patient selection is needed
Technological advances: image-guided radiotherapy, Space OAR,
fiducial markers, MRI-based radiotherapy and robotic SBRT if possible
11/6/2022 78
79. SURGICAL REPORT- NCDB DATABASE
• V-VESCICLE INVOLVEMENT
• E- EXTRACAPSULAR EXTEANSION
• N-NODE POSITIVE
• O-OVIBIOUS PERSISTANT ANTIGEN
• M-MARGIN POSITIVE
11/6/2022 79
MORE THAN HALF OF PATIENTS
80. WHY DOUBLE TROUBLE?
• Most of the post op prostate
patients require radiation
• Why we should choose surgery,
where SBRT 5 days treatment
is available
• It is double trouble when we
add radiotherapy after surgery
as dual toxicity.
• We can complete the
treatment before their
preanaesthetic evaluation
11/6/2022 80